Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines

Table 3

Odds ratio of all-cause and cardiovascular (CV) mortality by achievement of KDIGO clinical guideline, Ca target.

	OR (95% CI)
	Model 1		Model 2		Model 3
Ca (mg/dL), all-cause
<7.9	2.41 (1.22~4.77)	0.01	3.24 (1.19~8.80)	0.02	7.11 (1.25~40.3)	0.02
7.9~9.9	1.00		1.00		1.00
>9.9	1.51 (0.92~2.48)	0.10	1.56 (0.88~2.77)	0.13	1.46 (0.77~2.78)	0.24
Ca (mg/dL), CV
<7.9	2.02 (0.60~6.83)	0.25	0.67 (0.08~5.73)	0.71	0.71 (0.06~8.95)	0.78
7.9~9.9	1.00		1.00		1.00
>9.9	0.82 (0.25~2.69)	0.73	1.01 (0.28~3.58)	0.99	0.89 (0.23~3.47)	0.86

Logistic regression model:
Model 1: unadjusted.
Model 2: adjusted for age, sex, hemodialysis vintage, etiology of renal failure, EPO, vitamin-D analogs, antihypertensive agent, iron use, and parathyroidectomy.
Model 3: model 2 + baseline laboratory results (albumin, hemoglobin, cholesterol, triglyceride, glucose (fasting), ferritin, P, iPTH, potassium, uric acid, urea, and cardiac-thoracic ratio).